search
Back to results

Evaluation of a Cone-beam CT Scanner for Image Guided Radiotherapy (CONFIGURE)

Primary Purpose

Head and Neck Cancer, Lung Cancer, Breast Cancer

Status
Completed
Phase
Not Applicable
Locations
Netherlands
Study Type
Interventional
Intervention
Novel CBCT Imaging
Sponsored by
Varian, a Siemens Healthineers Company
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Head and Neck Cancer

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • The patient will be treated with external beam photon radiotherapy at Maastro for head-and-neck cancer, stage I lung cancer, stage II-IV lung cancer, left breast cancer, or tumours in the abdominal or pelvic region.
  • Age ≥ 18 years
  • Ability to understand the requirements of the study and to give written informed consent, as determined by the treating physician
  • Provision of written informed consent

Exclusion Criteria:

  • Patient is pregnant

Sites / Locations

  • Maastricht Radiation Oncology

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Novel CBCT Imaging

Arm Description

All subjects undergo one additional imaging session with the novel CBCT imaging system.

Outcomes

Primary Outcome Measures

Image quality
Comparison of image quality produced by the novel cone-beam CT imaging system to the quality of standard cone-beam CT imaging and to that of conventional CT images used for radiotherapy planning purposes. For this objective, the image contrast-to-noise ratio (CNR) will be evaluated. CNR is frequently used to measure image quality.

Secondary Outcome Measures

Image suitability for radiation dose calculation
For this objective, targets and organs at risk will be delineated on the novel CBCT images acquired for each subject. The treatment plan created for the patient on the planning CT scan will be registered to the novel cone-beam CT dataset, the dose will be recalculated on the standard CBCT as well as the novel cone-beam CT. The delineations of target and OARs will either be copied, deformed or manually delineated on the CBCT images, the radiotherapy dose metrics for specific structures relevant for the anatomical site that is imaged will be compared to dose metrics from the original treatment plan.
Qualitative assessment of novel CBCT images
Qualitative assessment of the novel CBCT images will be obtained by presenting individual novel CBCT images as well as head-to-head comparisons of novel and standard CBCT images from the same patient to radiation oncologists and radiation therapists. The reviewers will be asked to evaluate the images on their suitability for anatomical contouring and patient positioning. Qualitative assessments will be determined using a 5-point Likert scale.

Full Information

First Posted
August 29, 2022
Last Updated
September 5, 2023
Sponsor
Varian, a Siemens Healthineers Company
search

1. Study Identification

Unique Protocol Identification Number
NCT05524454
Brief Title
Evaluation of a Cone-beam CT Scanner for Image Guided Radiotherapy
Acronym
CONFIGURE
Official Title
Evaluation of a Cone-beam CT Scanner for Image Guided Radiotherapy (CONFIGURE)
Study Type
Interventional

2. Study Status

Record Verification Date
September 2023
Overall Recruitment Status
Completed
Study Start Date
March 20, 2023 (Actual)
Primary Completion Date
August 18, 2023 (Actual)
Study Completion Date
August 18, 2023 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Varian, a Siemens Healthineers Company

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Device Product Not Approved or Cleared by U.S. FDA
Yes
Product Manufactured in and Exported from the U.S.
Yes
Data Monitoring Committee
No

5. Study Description

Brief Summary
This is a feasibility study investigating the image quality of a new, high-performance cone beam CT (CBCT) used for on-couch imaging during radiotherapy treatments.
Detailed Description
This study will examine the image quality generated by a new cone-beam CT (CBCT) imaging system integrated into an external beam radiation treatment delivery platform. Normally, CBCT images are acquired at the start of a daily radiation delivery treatment to align the patient with the images that were used to generate their radiation treatment plan. This alignment increases the precision of radiation delivery. This study will assess whether the improvements in image quality expected from the novel CBCT imaging system are sufficient for the images to be used for more than just patient alignment. The study will enroll patients who will be treated with external beam radiation therapy for the following conditions: head and neck cancers, stage I lung cancer, stage II to IV lung cancer, cancer in the left breast, tumors in the abdomen, and tumors in the pelvic region. Each patient will undergo one additional imaging session with the novel CBCT imaging system during which 1 or 2 CBCT images will be acquired. The number of novel CBCT images acquired depends on the location and type of the patient's tumor. The additional imaging session will occur on the same day as one of the patient's scheduled treatment delivery sessions to minimize impact on the patient's schedule. The patient's cancer treatment will not be affected by participation in this study. The methodology for the subject's treatment setup, CT simulation, treatment planning, image guidance and treatment delivery will be determined by the subject's treatment team. The images acquired by the novel CBCT imaging system will be compared to standard CBCT images acquired as part of the patient's treatment and to the CT simulation images used to define the patient's radiation treatment plan.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Head and Neck Cancer, Lung Cancer, Breast Cancer, Abdominal Cancer, Pelvic Cancer

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
This is a single-site study designed to generate data describing the quality and applicability of a novel on-couch CBCT imaging system for anatomy visualization and radiation treatment dosimetry planning.
Masking
None (Open Label)
Allocation
N/A
Enrollment
40 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Novel CBCT Imaging
Arm Type
Experimental
Arm Description
All subjects undergo one additional imaging session with the novel CBCT imaging system.
Intervention Type
Device
Intervention Name(s)
Novel CBCT Imaging
Intervention Description
One or two CBCT images are acquired on the novel CBCT imaging system.
Primary Outcome Measure Information:
Title
Image quality
Description
Comparison of image quality produced by the novel cone-beam CT imaging system to the quality of standard cone-beam CT imaging and to that of conventional CT images used for radiotherapy planning purposes. For this objective, the image contrast-to-noise ratio (CNR) will be evaluated. CNR is frequently used to measure image quality.
Time Frame
Within 1 month from the start of treatment
Secondary Outcome Measure Information:
Title
Image suitability for radiation dose calculation
Description
For this objective, targets and organs at risk will be delineated on the novel CBCT images acquired for each subject. The treatment plan created for the patient on the planning CT scan will be registered to the novel cone-beam CT dataset, the dose will be recalculated on the standard CBCT as well as the novel cone-beam CT. The delineations of target and OARs will either be copied, deformed or manually delineated on the CBCT images, the radiotherapy dose metrics for specific structures relevant for the anatomical site that is imaged will be compared to dose metrics from the original treatment plan.
Time Frame
Within 1 month from the start of treatment
Title
Qualitative assessment of novel CBCT images
Description
Qualitative assessment of the novel CBCT images will be obtained by presenting individual novel CBCT images as well as head-to-head comparisons of novel and standard CBCT images from the same patient to radiation oncologists and radiation therapists. The reviewers will be asked to evaluate the images on their suitability for anatomical contouring and patient positioning. Qualitative assessments will be determined using a 5-point Likert scale.
Time Frame
Within 1 month from the start of treatment

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: The patient will be treated with external beam photon radiotherapy at Maastro for head-and-neck cancer, stage I lung cancer, stage II-IV lung cancer, left breast cancer, or tumours in the abdominal or pelvic region. Age ≥ 18 years Ability to understand the requirements of the study and to give written informed consent, as determined by the treating physician Provision of written informed consent Exclusion Criteria: Patient is pregnant
Facility Information:
Facility Name
Maastricht Radiation Oncology
City
Maastricht
State/Province
Limburg
ZIP/Postal Code
6229 ET 12
Country
Netherlands

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Evaluation of a Cone-beam CT Scanner for Image Guided Radiotherapy

We'll reach out to this number within 24 hrs